A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

NCT01876251 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
30
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014 development. There were no safety/efficacy concerns behind the decision.

Conditions

Interventions

Sponsor

Pfizer